Compare Oscar Health Inc (OSCR) vs Visa Inc (V) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Visa Inc — how do they compare? Oscar Health Inc trades at $28.23 (market cap $9.28B), while Visa Inc trades at $353.98 (market cap $676.68B). The key difference: Visa Inc is far larger — about 72.9× Oscar Health Inc's market cap, and Visa Inc pays a 0.75% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| OSCR | V | |
|---|---|---|
Market Cap | $9.28B | $676.68B |
Sector | Health | Financials |
52-Week High | $32.18 | $365.14 |
52-Week Low | $10.85 | $295.52 |
Enterprise Value | $4.90B | $687.27B |
Volume | — | 10,431,336 |
Dividend Yield | — | 0.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.
The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.
Visa (V) trades at $353.42, down 1.98% on the day, with a bullish technical signal supported by moving averages and a consensus price target of $396.70. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $3.31 exceeding the $3.10 estimate. Revenue grew to $40.0 billion in 2025, though net income margin dipped to 50.14%. Recent news highlights Visa's expansion into AI-driven commerce and stablecoin partnerships, positioning it for future growth amid competitive fintech threats.
Visa's outlook remains positive with robust profitability and analyst support, but investors face risks from regulatory pressures and rising competition. The stock offers potential upside to the price target, supported by solid cash flow and strategic initiatives in digital payments. However, margin compression and macroeconomic volatility could challenge near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
